Viewing Study NCT05263193


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2025-12-27 @ 1:42 AM
Study NCT ID: NCT05263193
Status: COMPLETED
Last Update Posted: 2022-12-14
First Post: 2022-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module